16-166436-C-A
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PP3_Strong
The NM_001003938.4(HBM):c.261C>A(p.His87Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000672 in 1,547,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001003938.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HBM | NM_001003938.4 | c.261C>A | p.His87Gln | missense_variant | 2/3 | ENST00000356815.4 | NP_001003938.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBM | ENST00000356815.4 | c.261C>A | p.His87Gln | missense_variant | 2/3 | 1 | NM_001003938.4 | ENSP00000349270.3 | ||
HBM | ENST00000472539.5 | n.374C>A | non_coding_transcript_exon_variant | 2/3 | 5 | |||||
HBM | ENST00000496585.1 | n.374C>A | non_coding_transcript_exon_variant | 2/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152124Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000204 AC: 3AN: 147012Hom.: 0 AF XY: 0.0000369 AC XY: 3AN XY: 81208
GnomAD4 exome AF: 0.0000695 AC: 97AN: 1395824Hom.: 0 Cov.: 35 AF XY: 0.0000666 AC XY: 46AN XY: 690208
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152124Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74316
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 01, 2024 | The c.261C>A (p.H87Q) alteration is located in exon 2 (coding exon 2) of the HBM gene. This alteration results from a C to A substitution at nucleotide position 261, causing the histidine (H) at amino acid position 87 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at